# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Henrietta Lacks' family sues Novartis and Viatris for profiting from her HeLa cells without consent. The lawsuit seeks prof...
11 large-cap stocks saw significant gains in the last week, driven by positive earnings and guidance updates. Check if they'...
TD Cowen analyst Dan Brennan maintains Thermo Fisher Scientific (NYSE:TMO) with a Buy and raises the price target from $648 ...
Raymond James analyst Andrew Cooper maintains Thermo Fisher Scientific (NYSE:TMO) with a Outperform and raises the price tar...
RBC Capital analyst Conor McNamara maintains Thermo Fisher Scientific (NYSE:TMO) with a Outperform and raises the price targ...